2001
DOI: 10.1007/s002160000628
|View full text |Cite
|
Sign up to set email alerts
|

Multiparametric microsensor chips for screening applications

Abstract: The identification of drug targets for pharmaceutical screening can be greatly accelerated by gene databases and expression studies. The identification of leading compounds from growing libraries is realized by high throughput screening platforms. Subsequently, for optimization and validation of identified leading compounds studies of their functionality have to be carried out, and just these functionality tests are a limiting factor. A rigorous preselection of identified compounds by in vitro cellular screeni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
41
0

Year Published

2002
2002
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 59 publications
(42 citation statements)
references
References 0 publications
1
41
0
Order By: Relevance
“…Other drugs have similar as well as different effects on the rates of acidification and O 2 consumption and a cell membrane [2,4,17]. The effects depend on the specific phenotype and metabolism of the cell [18].…”
Section: Effect Of Cisplatinmentioning
confidence: 97%
“…Other drugs have similar as well as different effects on the rates of acidification and O 2 consumption and a cell membrane [2,4,17]. The effects depend on the specific phenotype and metabolism of the cell [18].…”
Section: Effect Of Cisplatinmentioning
confidence: 97%
“…Protein chips are well suited for this application when there is only a limited supply of cells or amount of drugs available for testing [53], especially in the high-throughput screening of lead compounds. Zhu et al [16] used a microarray of an entire eukaryotic proteome to screen different biochemical activities.…”
Section: Drug Screening and Testingmentioning
confidence: 99%
“…Such microarrays can be used to screen protein-drug interactions. To identify and validate lead compounds, in vitro cellular screening is necessary before further testing in, e.g., animal model [53]. Multiparametric cell monitoring with the Cell-Monitoring-System CMS may detect side effects more easily [54,55].…”
Section: Drug Screening and Testingmentioning
confidence: 99%
See 1 more Smart Citation
“…CMOS APS with 21 x 21 µm 2 Al electrodes with optional Aucoating (electroless deposition) (Imfeld et al, 2007; Multiparametric sensor with 6 µm 2 CPFET and Ø 10 µm Pd or Pt electrodes, ISFET pH electrode, interdigitated impedance electrodes, photodiodes, oxygen and T sensor (Baumann et al, 1999;Ehret et al, 2001;Baumann et al, 2002) (Cunningham et al, 2001;Mathieson et al, 2004) 61 R,S (3D) Hexagonally arranged, ≤ 200 µm high, partially hollow W needles with electroplated Pt-tips, insulated by SiO 2 and back-side connected to Al tracks, wire-bonded to ASIC readout & stimulation circuitry (Gunning et al, 2010) Table 1. List of groups and companies that have developed a particular MEA technology 6 sorted by first publication date, then author.…”
mentioning
confidence: 99%